All articles tagged with #china deals
The Readout highlights Eli Lilly’s two China deals, Akeso’s promising lung cancer bispecific, and ASCO-driven updates on pancreatic cancer therapies (including daraxonrasib results), alongside chatter about a high-profile Chinese lung cancer therapy and a broader regulatory debate over an old peptide, illustrating how deals, trials, and policy are shaping biotech today.
New Zealand has paused funding to the Cook Islands over recent China-related deals, citing concerns over trust and regional influence, as the Cook Islands seeks to balance its long-standing relationships with Western allies and China amidst regional tensions.
U.S. regulations aimed at excluding China from supply chains have forced South Korean EV battery makers, SK On, EcoPro, and GEM of China, to reconsider their joint venture plans. The venture, which aimed to produce precursor materials for electric vehicle batteries, was set to be located near China on reclaimed land in South Korea's Saemangeum National Industrial Complex.